VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

PTC Therapeutics, Inc. (PTCT) Total Return Calculator with Dividends Reinvested

PTC Therapeutics, Inc.

Popular:

The total return for PTC Therapeutics, Inc. (PTCT) stock is +60.00% over the past 12 months. So far it's down 15.25% this year. The 5-year total return is +59.10%, meaning $10,000 invested in PTCT stock 5 years ago would be worth $15,910 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in PTCT 1 year ago, it would be worth $18,406 today — you'd have gained $8,406.

With Dividends Reinvested$18,406+84.06%

Price Only (No DRIP)$18,406+84.06%

Period2025-05-06 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in PTCT

1Y$16,000+$6,000 (+60.0%)60.0% CAGR

3Y$11,652+$1,652 (+16.5%)5.2% CAGR

5Y$15,910+$5,910 (+59.1%)9.7% CAGR

10Y$94,535+$84,535 (+845.3%)25.2% CAGR

15Y$39,442+$29,442 (+294.4%)9.6% CAGR

20Y$39,442+$29,442 (+294.4%)7.1% CAGR

30Y$39,442+$29,442 (+294.4%)4.7% CAGR

PTC Therapeutics, Inc. did not pay dividends during this period. Total return = price return.

Loading PTCT total return...

As of 2026-05-06

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-15.25%	—	-15.25%	—	$8,475
1Y	+60.00%	60.00%	+60.00%	—	$16,000
3Y	+16.52%	5.23%	+16.52%	—	$11,652
5Y	+59.10%	9.73%	+59.10%	—	$15,910
10Y	+845.35%	25.19%	+845.35%	—	$94,535
15Y	+294.42%	9.58%	+294.42%	—	$39,442
20Y	+294.42%	7.10%	+294.42%	—	$39,442
30Y	+294.42%	4.68%	+294.42%	—	$39,442

Risk & Highlights

Best Year+209.26%2014

Worst Year-64.65%2016

Max Drawdown-27.55%2025-11-26 → 2026-03-06

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-11.14%	-11.14%	—	+0.41%	-11.6pp
2025	+65.56%	+65.56%	—	+16.64%	+48.9pp
2024	+60.98%	+60.98%	—	+24.00%	+37.0pp
2023	-27.78%	-27.78%	—	+24.81%	-52.6pp
2022	-10.36%	-10.36%	—	-19.95%	+9.6pp

PTCT outperformed the S&P 500 by 31.56pp over the past year (+60.00% vs +28.44%).

Loading summary...

PTCT Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
PTCTPTC Therapeutics, Inc.	$5.4B	-5.6%	-15.2%	+60.0%	—	+16.5%	+59.1%	+845.3%
SRPTSarepta Therapeutics, Inc.	$2.3B	-4.4%	+2.3%	-65.8%	—	-83.4%	-70.1%	+30.0%
BMRNBioMarin Pharmaceutical Inc.	$10.2B	-5.3%	-10.4%	-14.2%	—	-44.9%	-31.5%	-34.1%
RAREUltragenyx Pharmaceutical Inc.	$2.5B	+9.4%	+6.0%	-35.7%	—	-47.0%	-76.4%	-60.0%
ALNYAlnylam Pharmaceuticals, Inc.	$40.2B	-8.8%	-24.8%	+10.1%	—	+42.0%	+127.0%	+412.7%
ACADACADIA Pharmaceuticals Inc.	$3.8B	+0.1%	-14.5%	+47.6%	—	+1.9%	+15.2%	-17.4%
FOLDAmicus Therapeutics, Inc.	$4.5B	+0.3%	+1.5%	+121.9%	—	+19.3%	+51.1%	+121.9%
KRYSKrystal Biotech, Inc.	$8.4B	+8.7%	+15.3%	+75.3%	—	+237.8%	+296.0%	+2574.5%
RYTMRhythm Pharmaceuticals, Inc.	$6.3B	+6.2%	-12.1%	+43.3%	—	+453.1%	+333.8%	+207.7%
LGNDLigand Pharmaceuticals Incorporated	$4.6B	+14.1%	+22.2%	+118.4%	—	+192.8%	+78.4%	+96.5%
PRAXPraxis Precision Medicines, Inc.	$7.5B	+7.5%	+16.4%	+755.5%	—	+1938.5%	-15.6%	-20.1%

Compare:PTCT vs SRPT PTCT vs BMRN PTCT vs RARE PTCT vs SRPT vs BMRN

About PTCT Dividend Returns

PTC Therapeutics, Inc. (PTCT) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of PTCT over the past year?

PTC Therapeutics, Inc. (PTCT) delivered a return of 60.00% over the past year. Since PTCT does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in PTCT be worth today?

A $10,000 investment in PTC Therapeutics, Inc. one year ago would be worth $16,000 today, representing a gain of $6,000.

Q3Does PTCT pay dividends?

PTC Therapeutics, Inc. (PTCT) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For PTCT, the total return equals the price-only return.

Q4Did PTCT beat the S&P 500?

Yes, PTC Therapeutics, Inc. (PTCT) outperformed the S&P 500 by 31.56 percentage points over the past year. PTCT delivered a total return of 60.00%, compared to the S&P 500's 28.44%. This 31.56pp alpha means investors in PTCT earned more than a passive S&P 500 index fund.

Q5What is PTCT's worst drawdown?

PTC Therapeutics, Inc. (PTCT) experienced a maximum drawdown of -27.55% over the past year, declining from its peak on 2025-11-26 to its trough on 2026-03-06. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is PTCT's long-term total return over 10, 20, or 30 years?

Here are PTC Therapeutics, Inc. (PTCT)'s long-term returns with dividends reinvested. Over 10 years, the total return is 845.3% (25.2% CAGR) — $10,000 would have grown to $94,535. Over 20 years: 294.4% total return (7.1% CAGR) — $10,000 → $39,442. Over 30 years: 294.4% total return (4.7% CAGR) — $10,000 → $39,442. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was PTCT's best and worst year?

PTC Therapeutics, Inc.'s best calendar year was 2014 with a total return of 209.3%. Its worst year was 2016 with a total return of -64.6%. This range shows the volatility investors should expect — the difference between the best and worst year is 273.9 percentage points.